We have SAHPRA as well as Italian Ministry of Health approval for BOSON Rapid SARS-CoV-2 Antigen test card to be distributed in South Africa and Italia.
This product is cost-effective and a rapid point-of-care solution, making it a valuable prospect for the robust African and Italian setting and market. The ease of using an oropharyngeal swap, allows this product to be used on small children.
Boson antigen tests detects antigen based on the viral nucleocapsid protein coded by the very stable N gene.
Overall accuracy: 98,3%
Thola Biotechnologies is a subsidiary of Elu Healthcare Holdings, an African based biotechnology company that was formed to provide solutions to the medical services sector, born out of the Coronavirus pandemic.
Thola Biotechnologies © 2021 | Website Design by Versys Media